CanSino’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

CanSino is a biotechnology company focuses on the research, development, manufacturing and commercialization of vaccine products. Read more

Xuefeng Yu's photo - Chairman & CEO of CanSino

Chairman & CEO

Xuefeng Yu

CEO Approval Rating

79/100

Founded:

2009

Status:

PublicHong Kong Stock Exchange06185

Annual Revenue
Employees
Headquarters
- -

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Sinovac is seen as one of CanSino's top competitors. Sinovac was founded in 1999, and is headquartered in Haidian District, Beijing Municipality. Like CanSino, Sinovac also competes in the Pharmaceuticals industry. Sinovac generates $245.9M more revenue vs. CanSino.

GeoVax is a top competitor of CanSino. GeoVax was founded in 2001, and its headquarters is in Smyrna, Georgia. GeoVax operates in the Health Care Supplies industry. GeoVax has 6 more employees than CanSino.

Etubics is CanSino's #3 rival. Etubics was founded in Seattle, Washington} in 2003. Like CanSino, Etubics also operates in the Pharmaceuticals field. Compared to CanSino, Etubics generates $6.8M more revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Merck a competitor of CanSino?

Quarterly and Annual Revenue

Coming soon for CanSino!

Annual Revenue

$ < 1M

CanSino's revenue is the ranked 18th among it's top 10 competitors. The top 10 competitors average 4.9B.

Acquisitions

No recent acquisitions found related to CanSino

CanSino Funding History

$65M$226M

Since CanSino was founded in 2009, it has participated in 2 rounds of funding. In total CanSino has raised $226.0M. CanSino's last funding round was on Mar 2019 for a total of $161.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Mar 2019
$161M

Equity
Apr 2017
$65M
-

Total Funding: $226M

Since CanSino was founded in 2009, it has participated in 2 rounds of funding. In total CanSino has raised $226.0M. CanSino's last funding round was on Mar 2019 for a total of $161.0M

Investments

No recent investments found related to CanSino

CanSino News

September 3, 2020Post Online Media

CanSino Biologics kicks off Phase III vaccine clinical trials in Russia

Phase III clinical trials on a coronavirus vaccine candidate developed by Chinese biopharmaceutical f... See more »
September 2, 2020The Economic Times

Covid-19 vaccine front-runner held back by China's spat with Canada

Chinese customs hasn't approved shipments of CanSino's vaccine to Canada, the National Research Counc... See more »
August 28, 2020BioPharma Dive

CanSino said to seek early authorization of coronavirus vaccine

The reported talks between Cansino and several countries highlight the urgency with which governments... See more »
August 27, 2020BioPharma Dive

CanSino, Canada abandon plans for a coronavirus vaccine trial

The planned study of CanSino's experimental shot would have been a first for Canada, building on a le... See more »
August 18, 2020Reuters

China's CanSino says hasn't begun enrolling people for Phase 3 trial

China's CanSino Biologics said on Tuesday it had not started enrolling participants for a late-stage ... See more »

Headquarters

185 South Avenue

, Tianjin Municipality300457

022-58213600

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

CanSino is a biotechnology company focuses on the research, development, manufacturing and commercialization of vaccine products. CanSino was founded in 2009. CanSino's headquarters is located in Tianjin Municipality, CN 300457. It has raised 226.0M i...

CEO

CanSino's Chairman & CEO, Xuefeng Yu, currently has an approval rating of 79%. CanSino's primary competitors are Sinovac, GeoVax & Etubics.

Website

cansinotech.com

Frequently Asked Questions about CanSino

  1. When was CanSino founded?

    CanSino was founded in 2009
  2. Who is CanSino's CEO?

    CanSino's CEO is Xuefeng Yu
  3. How much revenue does CanSino generate?

    CanSino generates $ < 1M in revenue
  4. How much funding does CanSino have?

    CanSino has historically raised $226M in funding
  1. Where is CanSino's headquarters?

    CanSino's headquarters is in Tianjin Municipality, CN
  2. How many employees does CanSino have?

    CanSino has 0 employees
  3. What sector does CanSino operate in?

    CanSino is in Pharmaceuticals
  4. Who are CanSino's competitors?

    CanSino's top competitors are Sinovac, GeoVax, Etubics